Bionexus Gene Lab approved the appointment of Chi Yuen Leong as the Chief Executive Officer and a director, effective October 12. Leong has no family relationship with any director or executive officer of the company. He was not involved in any transaction with the company during the past two years. Leong served as the president and director from the company’s inception to August 2022 and has been working with and guiding Bionexus Gene Lab’s listing on OTC and Nasdaq. Leong entered into an employment agreement with the company dated October 12 and agreed to receive an annual compensation of $24,000.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>